Portfolio company
Proteomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
NAUT
This company develops a proteomic analysis platform to measure proteins for researchers, drug developers and diagnostic organisations.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
Standardbiotools
This company develops genomic and proteomic analytical instruments and consumables for life sciences researchers focused on human health breakthroughs.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
